Kaneka Pharma Europe will present new applications for its flagship Kaneka QH ubiquinol form of CoQ10, as well as fat-burning Glavonoid licorice root extract.
At Health Ingredients Europe, Kaneka Pharma Europe will present new applications for its flagship Kaneka QH ubiquinol form of CoQ10. As a significant part of the respiratory chain inside mitochondrial cells, CoQ10 is important for energy production. Ubiquinol is the reduced form of CoQ10. Because it is already in its active form and does not have to be converted by the body, ubiquinol is effective more rapidly, the company explains. Additionally, the company will present thelicorice root extract Glavonoid, which the firm says helps reduce visceral fat. Glavonoid recently gained Novel Food statusfrom the European Commission. The polyphenols derived from licorice root (Glycyrrhiza glabra L.) have been discovered to ameliorate abdominal obesity and to target visceral fat in particular, thanks to a unique two-way efficiency profile:on one hand, it increases the body’s own fat-burning ability, and on the other hand, it decreases fat synthesis by down-regulating genes that are involved in fatty acid development, the company explains.
Booth D2
CRN NY State lawsuit update: Dispatch from SupplySide East 2024
April 18th 2024CRN's Steve Mister updates Nutritional Outlook about its ongoing litigation against NY State. The organization sued the state to prevent the enforcement of law that bans sale of weight management supplements to minors.
Microalgae extract supports metabolic health and bone mass during diet and exercise routine
April 11th 2024The extract from Microphyt, called PhaeOptim, was shown to complement weight management strategies that include diet and exercise by support bone mass, aerobic capacity, resting heart rate, and blood lipid profiles.